Albemarle clears a new investor milestone, specialty chemicals stock in focus after Assenagon stake lift

By Julia Schmitt, Sector & Peer Group desk. Reviewed prior to publication on 2026-06-29, 12:17.

Albemarle Corp. (US0126531013) starts the week with fresh attention from institutional investors. The specialty chemicals group, listed on the NYSE under ticker ALB, features in a new 13F disclosure highlighting a marked position increase by Assenagon Asset Management.MarketBeat summary of Assenagon’s 13F filing

What the latest filing shows

According to the MarketBeat report, Assenagon Asset Management S.A. grew its position in Albemarle by 37.6 percent in the first quarter of 2026, taking its stake to around 8.50 million US dollars based on the latest 13F filing with the SEC.Assenagon position change and stake size The disclosure underlines continuing institutional interest in the company after a volatile period for lithium-exposed names.

The same filing highlights Albemarle’s status as a diversified specialty chemicals player, with a business mix spanning lithium, bromine and catalysts, and feeding into sectors ranging from electric vehicles to energy storage and industrial applications.MarketBeat profile on Albemarle’s operations Institutional ownership is one of the metrics many investors watch in the S&P 500 chemicals segment, where peers include names such as FMC and Sociedad Química y Minera de Chile.

Consensus targets remain well above spot

Analyst data compiled by MarketScreener show Albemarle with a recent closing price around 133.70 US dollars, while the average target price sits at 212.63 dollars, indicating a sizeable implied upside from current levels.MarketScreener consensus and target price data The stock is categorized in the basic materials sector, specialty chemicals industry, and is a constituent of the S&P 500 index.

Consensus estimates reflect the group’s earnings profile after a strong first quarter of 2026, where Albemarle reported earnings per share of 2.95 dollars, clearly beating the consensus of 1.24 dollars.Quarterly EPS and revenue figures cited by MarketBeat Revenue in that period reached 1.43 billion dollars, versus analyst expectations of 1.34 billion, underscoring a robust demand backdrop despite lower lithium prices.

The business behind the stock

Albemarle’s core business focuses on specialty chemicals with three main segments: lithium, bromine specialties and catalysts, serving automotive, energy storage, electronics and refining customers worldwide.Company overview and segment structure Lithium products are used in battery materials for electric vehicles and stationary storage systems, while bromine is applied in fire safety, water treatment and other industrial uses.

Where the shares trade today

Albemarle shares (US0126531013) trade on the NYSE under the symbol ALB. As of 2026-06-26, 15:59 Eastern time, the shares closed at 133.69 US dollars, with extended-hours trading later showing 132.75 dollars according to MarketBeat price data.Latest Albemarle share price on the NYSE

This text is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell any security, or a solicitation of any kind. Figures and assessments are based on sources cited and may change with new data.